Anthony T. Reder to Rituximab
This is a "connection" page, showing publications Anthony T. Reder has written about Rituximab.
Connection Strength
0.236
-
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies. CNS Drugs. 2021 03; 35(3):317-330.
Score: 0.183
-
Effectiveness of rituximab versus oral immunosuppressive therapies in neuromyelitis optica spectrum disorder in a racially diverse cohort of subjects: A single-center retrospective study. Mult Scler Relat Disord. 2023 Jun; 74:104718.
Score: 0.053